Bentham Science Logo
Journal Cover

Track Your Manuscript:


Infectious Disorders - Drug Targets

Formerly: Current Drug Targets - Infectious Disorders

Volume 22, 8 Issues, 2022
ISSN: 2212-3989 (Online)
ISSN: 1871-5265 (Print)
This journal supports open access

Aims & Scope

Infectious Disorders - Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in infectious disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews/mini-reviews and research articles written by leaders in the field covering a range of current topics on drug targets involved in infectious disorders. As the discovery, identification, characterization and validation of novel human drug targets for anti-infective drug discovery continue to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug design, discovery and development. All aspects related to viral or bacterial diseases including HIV, AIDS and other sexually transmitted diseases (STDs) are also included in the scope of the journal.

Infectious Disorders - Drug Targets

,

Volume 22

-

Number 2




Editorial



Letter to the Editor



Letter to the Editor

DAMPening Severe COVID-19 with Dexamethasone

, 22(2): e270821195910

Cédric Annweiler*, Nicolas Papon, Jean-Marc Sabatier and Jean Barré


DOI: 10.2174/1871526521999210827142839


Review Article (Mini-Review)

A Mini Review on the Pathogenesis, Diagnosis and Treatment Options for COVID-19

, 22(2): e170322191922

Farzad Rahmani, Aghigh Ziaeemehr, Sajede Alijannejad, Gordon A Ferns, Majid Khazaei, Soodabeh Shahidsales* and Amir Avan*


DOI: 10.2174/1871526521666210301142223




Review Article

Skin Diseases and their Treatment Strategies in Sub-Saharan African Regions

, 22(2): e270921196808

Esra Tariq Anwar, Nandan Gupta, Omji Porwal*, Akanksha Sharma, Rishabha Malviya*, Amit Singh and Neeraj Kumar Fuloria


DOI: 10.2174/1871526521666210927120334


Infectious Disorders - Drug Targets, Volume 22 (2022) - Number 4


This issue is in progress but contains articles that are final and fully citable.

Infectious Disorders - Drug Targets, Volume 22 (2022) - Number 3


This issue is in progress but contains articles that are final and fully citable.

Articles Ahead of Print

Hydroxychloroquine (HCQ) Treatment for Hospitalized Patients with COVID- 19


Hristina Tsanovska, Iana Simova, Vladislav Genov, Todor Kundurzhiev, Jordan Krasnaliev, Vladimir Kornovski, Nikolai Dimitrov and Toni Vekov


DOI: 10.2174/1871526522666220303121209
View Abstract View on PubMed






A Case of Toxoplasma gondii and Strongyloides stercoralis Coinfection in an Immunocompromised Patient


Saumya Srivastava, Aditya Kundu, Haripriya Sivakumar, Vibhor Tak*, Durga Shankar Meena, Subhashree Samantray and Deepak Kumar


DOI: 10.2174/1871526522666220218114426
View Abstract View on PubMed


COVID-19 Infection in Pregnancy: A Review


Sabrina Jahan Mily, Kazi Mahmuda Akter, Nowshin Jabin, Saikat Mitra, Talha Bin Emran, Monisha Nandi, Sumit Kumar Baral, Md. Zia Uddin, Jewel Mallick, Arkajyoti Paul, Syed Uzair Ali Shah, Abdur Rauf, Ishaq N. Khan and Mohammad S. Mubarak*


DOI: 10.2174/1871526522666220105111358
View Abstract View on PubMed



Prevalence, Presentation and Outcome of Secondary Bloodstream Infections among COVID-19 Patients


Subhashree Samantaray, Priyabrat Karan, Anuradha Sharma*, Vijayalakshmi Nag, Naveen Dutt, Mahendra Kumar Garg, Pradeep Kumar Bhatia and Sanjeev Misra


DOI: 10.2174/1871526522666220418093450
View Abstract View on PubMed



Abstracts Ahead of Print


Native Iranian Medicinal Plants with Anti-Vaginal Infection Properties: A Systematic Review


Marzieh Rashidipour, Pegah Shakib*, Gholamreza Goudarzi, Yadollah Pournia, Maryam Karimi and Maryam Sarlak


DOI: 10.2174/1871526522666220501171551
View Abstract



‘Convalescent Plasma’- An Effective Treatment Option to Prevent Emerging nCOVID-19- A Review


Sumel Ashique*, Tahamina Khatun, Garima Sahu, Aakash Upadhyay, Archana Adhana, Nitish Kumar, Shubneesh Kumar and Navjot Sandhu


DOI: 10.2174/1871526522666220425103031
View Abstract



Infection and Severity of COVID-19 infection among health care workers: A report from Egypt


Ehab F Moustafa, Sahar M Hassany, Asmaa Mohamed Ahmed Soliman, Mohammed Ezz-Eldin, Nariman Zaghloul and Sherief Abd-Elsalam*


DOI: 10.2174/1871526522666220422105740
View Abstract


Epigenetic-related effects of COVID-19 on the human cells


Arezoo Faramarzi, Reza Safaralizadeh*, Narges Dastmalchi and Shahram Teimourian


DOI: 10.2174/1871526522666220420093029
View Abstract





Published Contents

Editor's Choice

Transmission Modes of COVID-19: A Systematic Review

, 2021; 21(6): 6 - 13

Esmaeil Mehraeen, Mohammad Amin Salehi, Farzane Behnezhad, Hamed Rezakhani Moghaddam and SeyedAhmad SeyedAlinaghi*


DOI: 10.2174/1871526520666201116095934




Ocular COVID-19: Eyes as a Reservoir to Conceal and Spread SARSCoV- 2

, 2021; 21(4): 480 - 483

Abdul Mannan Baig*, Saara Ahmad, Areeba Khaleeq, Hamna Rafique, Shafiqa Rajput, Mehaer Angez, Ayesha Hameed, Talha Nawaz and Preet Katyara


DOI: 10.2174/1871526520999200729182242



Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report

, 2021; 21(3): 468 - 472

Zahra Ahmadinejad, Faeze Salahshour, Omid Dadras, Hesan Rezaei and SeyedAhmad SeyedAlinaghi*


DOI: 10.2174/1871526520666200609125045



Clinical Effectiveness of a High Dose Versus the Standard Dose of Meropenem in Ventilator-associated Pneumonia Caused by Multidrugresistant Bacteria: A Randomized, Single-blind Clinical Trial

, 2021; 21(2): 274 - 283

Mahila Monajati, Shahram Ala*, Masoud Aliyali, Roya Ghasemian, Fatemeh Heidari, Mohammad Ahanjan, Siavash Moradi, Ali Sharifpour, Mojtaba Mojtahedzadeh and Ebrahim Salehifar


DOI: 10.2174/1871526520666200227102013



Monoclonal Antibodies Against Infectious Microbes: So Long and Too Little!

, 2021; 21(1): 4 - 27

Gerard M. Raj*, Rekha Priyadarshini, Sakthibalan Murugesan and Mangaiarkkarasi Adhimoolam


DOI: 10.2174/1871526520666200312154649



The In Vitro Study of Anti-leishmanial Effect of Naja naja oxiana Snake Venom on Leishmania major

, 2020; 20(6): 913 - 919

Nastaran Fallahi, Delavar Shahbazzadeh, Fatemeh Maleki, Marjaneh Aghdasi, Fatemeh Tabatabaie* and Khadijeh Khanaliha*


DOI: 10.2174/1871526520666200106121839




Clinical and Epidemiologic Features of Visceral Leishmaniasis in Children: A 6-year Study from an Iranian Referral Hospital

, 2020; 20(4): 461 - 466

Mohamadreza Abdolsalehi, Babak Pourakbari, Shima Mahmoudi, Mina Moradzadeh, Hossein Keshavarz and Setareh Mamishi*


DOI: 10.2174/1871526519666190613123217




Open Access Articles


PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs?

, 2019; 19(4): 337 - 349

Raphael Taiwo Aruleba*, Tayo Alex Adekiya, Babatunji Emmanuel Oyinloye, Priscilla Masamba, Londiwe Simphiwe Mbatha, Ashley Pretorius and Abidemi Paul Kappo




Burden of Multidrug Resistant Mycobacterium tuberculosis Among New Cases in Al-Madinah Al-Monawarah, Saudi Arabia

, 2017; 17(1): 14 - 23

Mogahid M. Elhassan, Hassan A. Hemeg, Miskelyemen A. Elmekki, Khalid A. Turkistani and Ahmed A. Abdul-Aziz





Most Cited Articles


Editorial

Counter-regulatory ‘renin-angiotensin’ system-based candidate drugs to treat COVID-19 diseases in SARS-CoV-2-infected patients

, 2020; 20(4): 407-408.

Cédric ANNWEILER, Zhijian CAO, Yingliang WU, Emmanuelle FAUCON, Stéphanie MOUHAT, Hervé KOVACIC and Jean-Marc SABATIER


DOI: 10.2174/1871526520666200518073329


Case Report

A patient with COVID-19 disease in a referral hospital in Iran: A typical case

, 2020; 20(4): 559-562.

Fereshteh Ghiasvand, Sepideh Zahak Miandoab, Hamid Harandi, Fereshteh Shahmari Golestan and Seyed Ahmad Seyed Alinaghi*


DOI: 10.2174/1871526520666200429115535


Review Article

SARS-CoV-2: The path of prevention and control

, 2021; 21(3): 358-362.

Amal A. Mohamed, Nouran Mohamed, Seham Mohamoud, Fawkia E. Zahran, Rania Abdelmonem Khattab, Dalia Ali El-Damasy, Eman Alsayed and Sherief Abd-Elsalam*


DOI: 10.2174/1871526520666200520112848




Review Article

Albendazole and treatment of hydatid cyst: Review of the literature

, 2019; 19(2): 101-104.

Azar B. Dehkordi, Behnam Sanei, Morteza Yousefi, Seyedeh M. Sharafi, Farhang Safarnezhad, Rasool Jafari and Hossein Y. Darani*


DOI: 10.2174/1871526518666180629134511



Review Article

Hepatitis C virus: Efficacy of new daas regimens

, 2020; 20(2): 143-149.

Amal Ahmed Mohamed, Naglaa El-Toukhy Ramadan El-Toukhy, Ebada Mohamed Said, Hoda Mohamed Rabie Gabal, Hossameldin AbdelAziz, Wahid Doss, Hadeel El-Hanafi, Hala H. El Deeb, Seham Mahmoud, Mahmoud Elkadeem, Hassan Salama Shalby and Sherief Abd-Elsalam*


DOI: 10.2174/1871526519666190121114003


Systematic Review Article

Efficacy of lopinavir/ritonavir compared with standard care for treatment of coronavirus disease 2019 (COVID-19): A systematic review

, August 2021; 21(5): 8-17.

Timotius Ivan Hariyanto, Elizabeth Kristine, Catherine Jillian Hardi and Andree Kurniawan*


DOI: 10.2174/1871526520666201029125725


Review Article

PZQ therapy: How close are we in the development of effective alternative anti-schistosomal drugs?

, 2019; 19(4): 337-349.

Raphael Taiwo Aruleba*, Tayo Alex Adekiya, Babatunji Emmanuel Oyinloye, Priscilla Masamba, Londiwe Simphiwe Mbatha, Ashley Pretorius and Abidemi Paul Kappo


DOI: 10.2174/1871526519666181231153139


Research Article

Synthesis, biological evaluation and molecular docking studies of new pyrazolines as an antitubercular and cytotoxic agents

, 2019; 19(3): 310-321.

Bontha Venkata Subrahmanya Lokesh*, Y. Rajendra Prasad and Afzal Basha Shaik


DOI: 10.2174/1871526519666181217120626



Research Article

High-level aminoglycoside resistance in enterococcus faecalis and enterococcus faecium; as a serious threat in hospitals

, 2020; 20(2): 223-228.

Mahmoud Khodabandeh, Mohsen Mohammadi , Mohammad Reza Abdolsalehi, Meysam Hasannejad-Bibalan , Mehrdad Gholami , Azadeh Alvandimanesh, Abazar Pournajaf and Ramazan Rajabnia*


DOI: 10.2174/1871526519666181130095954


Research Article

Sofosbuvir, pegylated interferon and ribavirin in the treatment of an Egyptian cohort with hepatitis C virus infection in real-life clinical practice

, 2019; 19(2): 179-184.

Sherief Abd-Elsalam*, Rehab Badawi, Sally Elnawasany, Mohamed Yousef, Loai Mansour, Nehad Hawash, Reham A. Elkhouly, Shaimaa Soliman, Amal Selim, Abdelrahman Kobtan and Asem Elfert


DOI: 10.2174/1871526518666180912121835



Most Accessed Articles


Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients

, 2020; 20(4): 407-408.

Annweiler, Cédric; Cao, Zhijian; Wu, Yingliang; Faucon, Emmanuelle; Mouhat, Stéphanie; Kovacic, Hervé; Sabatier, Jean-Marc


DOI: 10.2174/1871526520666200518073329



SARS-CoV-2: The Path of Prevention and Control

, 2021; 21(3): 358-362.

Mohamed, Amal A.; Mohamed, Nouran; Mohamoud, Seham; Zahran, Fawkia E.; Khattab, Rania Abdelmonem; El-damasy, Dalia Ali; Alsayed, Eman; Abd-Elsalam, Sherief


DOI: 10.2174/1871526520666200520112848



High-Level Aminoglycoside Resistance in Enterococcus Faecalis and Enterococcus Faecium; as a Serious Threat in Hospitals

, 2020; 20(2): 223-228.

Khodabandeh, Mahmoud; Mohammadi, Mohsen; Abdolsalehi, Mohammad Reza; Hasannejad-Bibalan, Meysam; Gholami, Mehrdad; Alvandimanesh, Azadeh; Pournajaf, Abazar; Rajabnia, Ramazan


DOI: 10.2174/1871526519666181130095954


Hepatitis C Virus: Efficacy of New DAAs Regimens

, 2020; 20(2): 143-149.

Mohamed, Amal Ahmed; El-Toukhy, Naglaa El-Toukhy Ramadan; Said, Ebada Mohamed; Gabal, Hoda Mohamed Rabie; AbdelAziz, Hossameldin; Doss, Wahid; El-Hanafi, Hadeel; Deeb, Hala H. El; Mahmoud, Seham; Elkadeem, Mahmoud; Shalby, Hassan Salama; Abd-Elsalam, Sherief


DOI: 10.2174/1871526519666190121114003





A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case

, 2020; 20(4): 559-562.

Ghiasvand, Fereshteh; Miandoab, Sepideh Zahak; Harandi, Hamid; Golestan, Fereshteh Shahmari; SeyedAlinaghi, SeyedAhmad


DOI: 10.2174/1871526520666200429115535


Comparison of HIV Indicators after the Implementation of a New Model for TB and HIV Management in an Iranian Prison

, 2020; 20(6): 778-783.

Farhoudi, Behnam; SeyedAlinaghi, SeyedAhmad; Ataeinia, Bahar; Hosseini, Mostafa; Jafari, Sirous; Alasvand, Ramin; Tashakoriyan, Mehrzad; Mohraz, Minoo


DOI: 10.2174/1871526519666191015151639



Hand Hygiene Compliance and Effectiveness Against Respiratory Infections Among Hajj Pilgrims: A Systematic Review.

, 2020; 20(3): 273-283.

Alqahtani, Amani S; Fakeerh, Mutaz; Bondagji, Daniah; Park, Silvia; Heywood, Anita E; Wiley, Kerrie E; Booy, Robert; Rashid, Harunor


DOI: 10.2174/1871526518666181001145041


Chloroquine as Chemoprophylaxis for COVID-19: Will This Work.

, 2021; 21(4): 473-474.

Abd-Elsalam, Sherief; Elkadeem, Mahmoud; Glal, Khadija Ahmed


DOI: 10.2174/1871526520666200726224802




Editor-in-Chief

graphic
Jean-Marc Sabatier
Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE, Cedex 20
(France)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets - Infectious Disorders was launched in 2001 and later renamed in 2006 as Infectious Disorders - Drug Targets.
New eBook

ebook-cover



You can view the contents of this eBook [here] or purchase it [here].

Advertisement

Jan-2022-ban

Related Journals

Related eBooks

eBooks Catalog